Ortho Clinical Diagnostics Holdings (OCDX) Financials
$17.63
As on 26-May-2022 16:00EDT
Market cap
$4,191 Mln
Revenue (TTM)
$2,036 Mln
P/E Ratio
--
P/B Ratio
9.5
Div. Yield
0 %
Cashflow ($ Mln) |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
286.60
|
46.10
|
143.00
|
69.60
|
68.00
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-43.60
|
-45.40
|
-68.50
|
-87.10
|
-118.00
|
|||||
|
Cash from Financing Activities
|
--
|
-74.70
|
55.80
|
-64.40
|
-8.20
|
84.90
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
168.30
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
-0.01
|
-0.24
|
-1.45
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
0.35
|
0.78
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
1.80
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
1.26
|
0.32
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
1.26
|
0.01
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-2.02
|
-7.67
|
-5.41
|
-16.62
|
--
|
|||||
|
ROE (%)
|
-0.10
|
18.09
|
23.24
|
21.38
|
38.00
|
--
|
|||||
|
ROA (%)
|
-0.01
|
-1.61
|
-6.06
|
-4.31
|
-6.75
|
--
|
|||||
|
EBIT Margin (%)
|
7.78
|
5.87
|
-1.94
|
2.69
|
0.83
|
11.64
|
|||||
|
Net Margin (%)
|
-0.02
|
-2.73
|
-12.00
|
-8.71
|
-13.92
|
-6.53
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.17
|
0.16
|
-0.02
|
0.01
|
0.00
|
--
|
|||||
|
EBIT Growth (%)
|
848.50
|
450.88
|
-170.52
|
225.50
|
-92.82
|
--
|
|||||
|
Net Profit Growth (%)
|
99.73
|
74.37
|
-35.05
|
36.94
|
-113.93
|
--
|
|||||
|
EPS Growth (%)
|
99.27
|
0.84
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
0.20
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
-89.81
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
9.47
|
11.88
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
13.55
|
26.90
|
--
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
18.66
|
21.39
|
--
|
--
|
--
|
--
|
|||||
|
High Price ($)
|
22.99
|
22.99
|
--
|
--
|
--
|
--
|
|||||
|
Low Price ($)
|
16.04
|
15.14
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
4,191.27
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
4.91
|
5.48
|
-3.69
|
-4.45
|
-5.57
|
--
|
|||||
|
Short term debt to equity ratio
|
0.17
|
0.15
|
-0.17
|
-0.21
|
-0.24
|
--
|
|||||
|
Current Ratio
|
1.89
|
1.75
|
1.37
|
1.20
|
1.33
|
--
|
|||||
|
Quick Ratio
|
1.29
|
1.22
|
0.92
|
0.83
|
0.87
|
--
|
|||||
|
Interest Coverage
|
1.22
|
0.82
|
-0.18
|
0.21
|
0.06
|
0.94
|
Operating Efficiency Ratios |
TTM | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 | Dec-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.84
|
12.59
|
18.04
|
19.34
|
18.58
|
--
|
|||||
|
Asset Turnover
|
0.52
|
0.60
|
0.51
|
0.50
|
0.48
|
--
|
|||||
|
Receivable days
|
--
|
51.49
|
68.99
|
68.98
|
67.85
|
--
|
|||||
|
Inventory Days
|
--
|
105.95
|
107.10
|
102.60
|
103.75
|
--
|
|||||
|
Payable days
|
--
|
59.35
|
69.29
|
72.36
|
65.59
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
98.08
|
106.79
|
99.22
|
106.00
|
--
|